Trials / Conditions / Pulmonary Embolism Subacute Massive

Pulmonary Embolism Subacute Massive

8 registered clinical trials studyying Pulmonary Embolism Subacute Massive — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Effect of iNO in Patients With Submassive and Massive PE NCT04996667	University of California, Los Angeles	Phase 2
Withdrawn	Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE NCT04855370	University of California, Los Angeles	N/A
Withdrawn	Artificial Intelligence to StrategiCally Enhance Pulmonary Embolism Response Team Activation NCT06246045	University Hospitals Cleveland Medical Center	N/A
Completed	Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk NCT07374978	Ain Shams University	N/A
Unknown	Catheter Directed Therapy in Intermediate Risk Pulmonary Embolism Patients NCT05612854	Assiut University	EARLY_Phase 1
Recruiting	Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Ko NCT07029841	Chinese University of Hong Kong	—
Completed	Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests NCT06667882	Semmelweis University	N/A
Terminated	Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embol NCT03988842	Victor Tapson, MD	Phase 4